In related news

  • Abbott’s (ABT) Diabetes Device Sales Drive Earnings Beat, Forecast

    Abbott Laboratories raised the lower end of its annual profit forecast as strong sales in medical devices drove first-quarter earnings and revenue above expectations.

  • Abbott beats quarterly profit estimates on strong medical device sales

    Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its annual forecast on robust sales of its medical devices, including glucose-monitoring products. Sales of Abbott's medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries delayed during the COVID-19 pandemic. Industry bellwether and rival Johnson & Johnson said on Tuesday it continues to expect...

  • Abbott Labs posts Q1 earnings beat

    Abbott Laboratories (ABT) reported first quarter results that topped Wall Street estimates on both the top and bottom lines. The healthcare products company also raised the lower end of its full-year earnings guidance range.  Yahoo Finance's Anjalee Khemlani breaks down the results in the video above. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.